PI11312 Methyl 2-amino-3-nitrobenzoate (CAS No.: 57113-91-4)

Methyl 2-amino-3-nitrobenzoate (CAS No.: 57113-91-4) Description

Methyl 2-amino-3-nitrobenzoate (C8H8N2O4) is a chemical intermediate used in pharmaceutical processes. Its defined molecular structure and powdered form facilitate handling and reproducibility in subsequent chemical reactions. The compound is produced under controlled synthesis protocols with regular analytical verification, ensuring that properties such as reactivity and impurity profiles align with process specifications for downstream applications.

Methyl 2-amino-3-nitrobenzoate (CAS No.: 57113-91-4) Applications

1.         Pharmaceutical Manufacturing
- Used as an intermediate in drug synthesis to achieve predictable reaction kinetics by utilising its defined reactivity profile.
- Applied in process optimisation to improve yield consistency by utilising its controlled impurity levels.

2.         Research and Development
- Employed as a standard reagent in formulation studies to obtain reproducible results by utilising its precise chemical structure.
- Used as a reference compound in synthesis methodology investigations to calibrate analytical instruments and validate procedures.

Methyl 2-amino-3-nitrobenzoate (CAS No.: 57113-91-4) Packing

The compound is packaged in air-tight, chemically resistant, moisture barrier materials and sealed within secondary containment to prevent contamination. The packaging is designed for secure transit and long-term storage at temperatures preferably below 25°C. Anti-static measures are integrated to reduce particulate interference. Customised packaging options with inert gas blanketing and specific labelling can be arranged per client requirements.

Additional Information

Pharmaceutical intermediates play a crucial role in the synthesis of active pharmaceutical ingredients. Understanding their chemical properties, such as molecular structure and impurity profiles, aids in designing efficient synthetic routes. Researchers rely on detailed analytical assessments to confirm the compound's consistency before integration into complex reaction schemes.

Advancements in organic synthesis have led to refined methods for intermediate production, focusing on reproducibility and compliance with regulatory standards. This improved understanding of chemical reactivity contributes to more predictable process outcomes and supports the development of effective, scalable manufacturing protocols.